136 related articles for article (PubMed ID: 35926449)
1. Taking the parkin brakes off of neuronal NLRP3 drives inflammasome activation and neurodegeneration in Parkinson's disease.
Zengeler KE; Lukens JR
Neuron; 2022 Aug; 110(15):2356-2358. PubMed ID: 35926449
[TBL] [Abstract][Full Text] [Related]
2. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.
Panicker N; Kam TI; Wang H; Neifert S; Chou SC; Kumar M; Brahmachari S; Jhaldiyal A; Hinkle JT; Akkentli F; Mao X; Xu E; Karuppagounder SS; Hsu ET; Kang SU; Pletnikova O; Troncoso J; Dawson VL; Dawson TM
Neuron; 2022 Aug; 110(15):2422-2437.e9. PubMed ID: 35654037
[TBL] [Abstract][Full Text] [Related]
3. Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease.
Yan YQ; Zheng R; Liu Y; Ruan Y; Lin ZH; Xue NJ; Chen Y; Zhang BR; Pu JL
Aging Cell; 2023 Jun; 22(6):e13834. PubMed ID: 37029500
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease.
Ahmed S; Kwatra M; Ranjan Panda S; Murty USN; Naidu VGM
Brain Behav Immun; 2021 Jan; 91():142-158. PubMed ID: 32971182
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Inflammasomes in Parkinson's disease and their Regulation by Parkin.
Yan YQ; Fang Y; Zheng R; Pu JL; Zhang BR
Neuroscience; 2020 Oct; 446():323-334. PubMed ID: 32795556
[TBL] [Abstract][Full Text] [Related]
6. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
7. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
[TBL] [Abstract][Full Text] [Related]
8. Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop.
Mouton-Liger F; Rosazza T; Sepulveda-Diaz J; Ieang A; Hassoun SM; Claire E; Mangone G; Brice A; Michel PP; Corvol JC; Corti O
Glia; 2018 Aug; 66(8):1736-1751. PubMed ID: 29665074
[TBL] [Abstract][Full Text] [Related]
9. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease.
Pike AF; Longhena F; Faustini G; van Eik JM; Gombert I; Herrebout MAC; Fayed MMHE; Sandre M; Varanita T; Teunissen CE; Hoozemans JJM; Bellucci A; Veerhuis R; Bubacco L
J Neuroinflammation; 2022 Feb; 19(1):50. PubMed ID: 35172843
[TBL] [Abstract][Full Text] [Related]
10. Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson's Disease.
Ahmed S; Panda SR; Kwatra M; Sahu BD; Naidu V
ACS Chem Neurosci; 2022 Jan; 13(1):53-68. PubMed ID: 34904823
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease: connecting mitochondria to inflammasomes.
Lawrence GMEP; Holley CL; Schroder K
Trends Immunol; 2022 Nov; 43(11):877-885. PubMed ID: 36229358
[TBL] [Abstract][Full Text] [Related]
13. From inflammasome to Parkinson's disease: Does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson's disease?
Si XL; Fang YJ; Li LF; Gu LY; Yin XZ; Jun-Tian ; Yan YP; Pu JL; Zhang BR
Exp Neurol; 2021 Feb; 336():113525. PubMed ID: 33161049
[TBL] [Abstract][Full Text] [Related]
14. Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.
de Araújo FM; Cuenca-Bermejo L; Fernández-Villalba E; Costa SL; Silva VDA; Herrero MT
Cell Mol Neurobiol; 2022 Jul; 42(5):1283-1300. PubMed ID: 33387119
[TBL] [Abstract][Full Text] [Related]
15. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
16. Inflammasome Activation in Parkinson's Disease.
Jewell S; Herath AM; Gordon R
J Parkinsons Dis; 2022; 12(s1):S113-S128. PubMed ID: 35848038
[TBL] [Abstract][Full Text] [Related]
17. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
Hou L; Qu X; Qiu X; Huang R; Zhao X; Wang Q
J Neuroinflammation; 2020 May; 17(1):148. PubMed ID: 32375810
[TBL] [Abstract][Full Text] [Related]
18. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
Wang S; Yuan YH; Chen NH; Wang HB
Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
[TBL] [Abstract][Full Text] [Related]
19. Treadmill exercise alleviates neuronal damage by suppressing NLRP3 inflammasome and microglial activation in the MPTP mouse model of Parkinson's disease.
Wang W; Lv Z; Gao J; Liu M; Wang Y; Tang C; Xiang J
Brain Res Bull; 2021 Sep; 174():349-358. PubMed ID: 34224819
[TBL] [Abstract][Full Text] [Related]
20. Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease.
Qin Y; Qiu J; Wang P; Liu J; Zhao Y; Jiang F; Lou H
Brain Behav Immun; 2021 Jan; 91():324-338. PubMed ID: 33039664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
